Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Amy Keating

Concepts (199)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Receptor Protein-Tyrosine Kinases
13
2016
276
2.520
Why?
Hematopoietic Stem Cell Transplantation
14
2021
552
2.510
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
2022
265
1.910
Why?
Proto-Oncogene Proteins
12
2016
713
1.850
Why?
Glioblastoma
5
2016
247
1.540
Why?
Antibodies, Bispecific
2
2021
28
0.980
Why?
Leukemia, Myeloid, Acute
5
2021
484
0.960
Why?
Neoplasm, Residual
2
2019
91
0.790
Why?
Stem Cell Transplantation
2
2019
151
0.750
Why?
Transplantation Conditioning
6
2021
177
0.730
Why?
Brain Neoplasms
4
2017
982
0.710
Why?
Poverty
1
2021
460
0.650
Why?
Receptors, Antigen, T-Cell
6
2022
606
0.630
Why?
Tissue Donors
1
2019
347
0.620
Why?
c-Mer Tyrosine Kinase
11
2016
58
0.610
Why?
Homocystinuria
2
2019
59
0.590
Why?
Antineoplastic Agents
7
2021
2035
0.550
Why?
Graft vs Host Disease
4
2021
223
0.550
Why?
Immunotherapy, Adoptive
5
2022
173
0.530
Why?
Transplantation, Heterologous
1
2014
201
0.530
Why?
Neoplasm Transplantation
1
2014
262
0.520
Why?
Protein Kinase Inhibitors
5
2016
853
0.520
Why?
RNA, Small Interfering
5
2014
599
0.520
Why?
Anilides
1
2014
78
0.520
Why?
Quinolines
1
2014
140
0.490
Why?
Carcinogenesis
1
2013
160
0.460
Why?
Child
23
2022
17860
0.440
Why?
Central Nervous System
1
2013
249
0.440
Why?
Cell Movement
3
2014
930
0.430
Why?
Cystathionine beta-Synthase
1
2011
62
0.420
Why?
Pediatrics
1
2019
1053
0.420
Why?
Unrelated Donors
3
2019
42
0.410
Why?
Chemokines
1
2011
237
0.390
Why?
Protein-Tyrosine Kinases
1
2013
446
0.390
Why?
Astrocytoma
1
2010
111
0.380
Why?
Cord Blood Stem Cell Transplantation
2
2021
97
0.380
Why?
Infant
14
2022
8097
0.360
Why?
Leukemia
2
2020
206
0.340
Why?
Child, Preschool
12
2022
9651
0.330
Why?
Apoptosis
5
2014
2607
0.330
Why?
Leukemia, T-Cell
1
2006
5
0.310
Why?
Lymphoma, T-Cell
1
2006
17
0.310
Why?
Cell Line, Tumor
7
2016
2887
0.300
Why?
Hyperglycemia
2
2020
336
0.300
Why?
Humans
41
2022
114578
0.290
Why?
Betaine
2
2019
63
0.290
Why?
Adolescent
15
2022
18658
0.290
Why?
Drug Resistance, Neoplasm
1
2010
681
0.290
Why?
Recurrence
4
2022
988
0.290
Why?
Young Adult
9
2022
10987
0.250
Why?
Retrospective Studies
12
2022
11642
0.240
Why?
Mice
10
2019
15432
0.230
Why?
Transplantation, Autologous
2
2019
196
0.220
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
49
0.220
Why?
Treatment Outcome
7
2021
9190
0.220
Why?
Siblings
2
2019
272
0.210
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
2013
53
0.210
Why?
Hematologic Neoplasms
1
2021
114
0.210
Why?
Flow Cytometry
3
2018
1164
0.200
Why?
Lymphoma, Non-Hodgkin
1
2020
78
0.200
Why?
Anemia, Aplastic
1
2020
31
0.200
Why?
Fetal Blood
1
2021
255
0.200
Why?
Neoplasms
4
2020
2066
0.200
Why?
Antineoplastic Agents, Immunological
1
2021
155
0.190
Why?
Histocompatibility
1
2019
32
0.190
Why?
Betaine-Homocysteine S-Methyltransferase
1
2019
10
0.190
Why?
Signal Transduction
6
2014
4891
0.190
Why?
Animals
12
2019
34690
0.190
Why?
Taurine
1
2019
43
0.180
Why?
Immunologic Deficiency Syndromes
1
2019
82
0.180
Why?
WT1 Proteins
1
2018
12
0.180
Why?
Molecular Targeted Therapy
2
2013
380
0.180
Why?
Male
16
2021
60818
0.180
Why?
Multiple Myeloma
1
2019
91
0.170
Why?
Cell Survival
5
2014
1134
0.170
Why?
Female
15
2021
63070
0.170
Why?
Central Nervous System Neoplasms
1
2019
125
0.170
Why?
Calcineurin Inhibitors
1
2017
63
0.160
Why?
Polyploidy
1
2016
23
0.160
Why?
Cell Proliferation
3
2016
2368
0.150
Why?
Neuroblastoma
1
2017
127
0.150
Why?
Infant, Newborn
4
2019
5045
0.150
Why?
Extracellular Signal-Regulated MAP Kinases
2
2014
173
0.150
Why?
Methotrexate
1
2017
240
0.150
Why?
Mice, Nude
2
2014
696
0.150
Why?
Incidence
2
2019
2454
0.150
Why?
Cellular Senescence
1
2016
147
0.150
Why?
Mice, Transgenic
3
2013
2101
0.140
Why?
Gene Knockdown Techniques
3
2013
320
0.140
Why?
African Americans
1
2021
963
0.140
Why?
Pentacyclic Triterpenes
1
2014
13
0.140
Why?
Cell Death
1
2016
337
0.140
Why?
Neoplasm Invasiveness
2
2014
450
0.140
Why?
Hypoglycemia
1
2019
387
0.130
Why?
Adenine
1
2016
254
0.130
Why?
Critical Illness
1
2019
583
0.130
Why?
Phosphorylation
3
2014
1728
0.130
Why?
Piperazines
1
2016
328
0.130
Why?
Health Services Accessibility
1
2021
805
0.130
Why?
Endoplasmic Reticulum Stress
1
2014
92
0.130
Why?
Enzyme Activation
2
2016
956
0.130
Why?
Adult
9
2022
32077
0.120
Why?
Transplantation, Homologous
3
2020
471
0.120
Why?
Intercellular Signaling Peptides and Proteins
3
2016
373
0.120
Why?
Whole-Body Irradiation
1
2012
77
0.120
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2011
30
0.110
Why?
rhoA GTP-Binding Protein
1
2011
79
0.110
Why?
Chemokine CCL4
1
2011
21
0.110
Why?
Oncogene Proteins
2
2010
63
0.110
Why?
Proto-Oncogene Proteins c-akt
1
2014
457
0.110
Why?
Antigens, CD19
2
2022
89
0.110
Why?
Blood Glucose
1
2020
1898
0.110
Why?
Interleukin-1alpha
1
2011
58
0.110
Why?
Tumor Cells, Cultured
2
2010
1002
0.110
Why?
Interleukin-17
1
2011
90
0.110
Why?
Thymus Neoplasms
1
2010
21
0.100
Why?
Thymoma
1
2010
32
0.100
Why?
Liver
1
2019
1832
0.100
Why?
RNA Interference
1
2011
502
0.100
Why?
Drug Evaluation, Preclinical
1
2010
196
0.100
Why?
Drug Delivery Systems
2
2009
336
0.090
Why?
Survivors
1
2012
405
0.090
Why?
Dose-Response Relationship, Drug
1
2014
2187
0.090
Why?
Interleukin-1beta
1
2011
416
0.090
Why?
Quality of Life
1
2019
2230
0.090
Why?
Allografts
2
2018
117
0.080
Why?
Interleukin-6
1
2011
706
0.080
Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
15
0.080
Why?
Gene Expression
1
2011
1524
0.080
Why?
Xenograft Model Antitumor Assays
3
2014
779
0.070
Why?
Tumor Necrosis Factor-alpha
1
2011
1242
0.070
Why?
Survival Analysis
2
2020
1410
0.070
Why?
Antibodies, Monoclonal
1
2011
1294
0.070
Why?
DNA Primers
1
2006
580
0.070
Why?
Cohort Studies
3
2019
5000
0.070
Why?
Mice, Inbred C57BL
3
2013
5137
0.060
Why?
Gene Expression Regulation, Neoplastic
3
2016
1199
0.060
Why?
Vidarabine
1
2022
27
0.060
Why?
Oxidative Stress
1
2009
1231
0.060
Why?
Macrophages
1
2009
1315
0.060
Why?
Base Sequence
1
2006
2278
0.060
Why?
Risk Factors
3
2020
9078
0.060
Why?
Neoplasm Recurrence, Local
2
2021
805
0.050
Why?
Gene Expression Regulation, Leukemic
2
2013
59
0.050
Why?
Apoptosis Regulatory Proteins
2
2014
212
0.050
Why?
Hematopoiesis
1
2021
175
0.050
Why?
Tumor Burden
2
2014
288
0.050
Why?
Melphalan
1
2019
34
0.050
Why?
Hepatic Veno-Occlusive Disease
1
2019
12
0.050
Why?
Severe Combined Immunodeficiency
1
2019
19
0.050
Why?
Cost of Illness
1
2021
296
0.050
Why?
Graft Survival
1
2021
454
0.050
Why?
Prognosis
2
2017
3546
0.040
Why?
Mice, Knockout
2
2019
2835
0.040
Why?
Intensive Care Units, Pediatric
1
2019
197
0.040
Why?
Autografts
1
2017
38
0.040
Why?
Cause of Death
1
2019
390
0.040
Why?
Mortality
1
2019
326
0.040
Why?
Outpatients
1
2019
263
0.040
Why?
Disease-Free Survival
1
2018
685
0.040
Why?
Feasibility Studies
1
2019
749
0.040
Why?
Neural Stem Cells
1
2016
102
0.040
Why?
Lung Diseases, Interstitial
1
2019
390
0.030
Why?
Dacarbazine
1
2014
112
0.030
Why?
Survival Rate
1
2019
1859
0.030
Why?
Acute Disease
1
2017
993
0.030
Why?
Risk
1
2017
943
0.030
Why?
Cyclic AMP Response Element-Binding Protein
1
2013
159
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2013
326
0.030
Why?
Registries
1
2019
1915
0.030
Why?
Phosphotransferases
1
2010
33
0.030
Why?
Chronic Disease
1
2017
1649
0.030
Why?
Thymectomy
1
2010
16
0.030
Why?
Prospective Studies
1
2022
6288
0.030
Why?
Remission Induction
1
2010
267
0.020
Why?
Chemotherapy, Adjuvant
1
2010
327
0.020
Why?
Disease Models, Animal
1
2019
3828
0.020
Why?
Mice, SCID
1
2009
357
0.020
Why?
Mice, Inbred NOD
1
2009
561
0.020
Why?
Tumor Microenvironment
1
2010
394
0.020
Why?
Radiography
1
2010
850
0.020
Why?
Cognition Disorders
1
2012
582
0.020
Why?
Neuropsychological Tests
1
2012
1106
0.020
Why?
Combined Modality Therapy
1
2010
1217
0.020
Why?
Jurkat Cells
1
2006
138
0.020
Why?
Enzyme Inhibitors
1
2010
930
0.020
Why?
RNA, Neoplasm
1
2006
88
0.020
Why?
Epigenesis, Genetic
1
2010
488
0.020
Why?
Neovascularization, Pathologic
1
2008
295
0.020
Why?
United States
1
2022
12551
0.020
Why?
Clinical Trials as Topic
1
2010
1004
0.020
Why?
Sex Factors
1
2010
1971
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
1089
0.020
Why?
Cell Line
1
2009
2924
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1390
0.010
Why?
Middle Aged
1
2021
28854
0.010
Why?
Models, Biological
1
2008
1807
0.010
Why?
Transcription, Genetic
1
2006
1460
0.010
Why?
T-Lymphocytes
1
2006
1808
0.010
Why?
Keating's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)